S Siena Selected Research

S Siena Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 03/2000
21	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2002
8	Breast Neoplasms (Breast Cancer) 03/2010 - 03/2000
7	Disease Progression 06/2017 - 05/2002
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 10/2006
3	Adenocarcinoma 04/2016 - 03/2007
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2015 - 09/2001
3	Ovarian Neoplasms (Ovarian Cancer) 05/2012 - 10/2006
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2007 - 08/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2006
2	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2010
2	Nasopharyngeal Carcinoma 02/2012 - 01/2004
2	Brain Neoplasms (Brain Tumor) 03/2010 - 01/2001
2	Melanoma (Melanoma, Malignant) 03/2010 - 01/2001
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 02/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2016
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Ewing Sarcoma (Sarcoma, Ewing) 07/2011
1	Mesothelioma 05/2009
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2006
1	Infections 06/2005
1	Kidney Neoplasms (Kidney Cancer) 11/2004
1	Leukemia 08/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2003
1	Alopecia (Baldness) 08/2003
1	Neutropenia 01/2003
1	Febrile Neutropenia 01/2003
1	Asthenia 05/2002
1	Testicular Neoplasms (Testicular Cancer) 09/2001

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2001
6	Panitumumab (Vectibix)FDA Link 01/2018 - 12/2007
6	Cetuximab (Erbitux)FDA Link 08/2017 - 06/2006
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 06/2006
5	Temozolomide (Temodar)FDA LinkGeneric 01/2018 - 01/2001
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	Phosphotransferases (Kinase)IBA 11/2019 - 06/2001
3	Cisplatin (Platino)FDA LinkGeneric 10/2009 - 01/2001
3	Monoclonal AntibodiesIBA 06/2006 - 09/2001
2	Cell-Free Nucleic AcidsIBA 01/2018 - 09/2015
2	Bevacizumab (Avastin)FDA Link 08/2017 - 11/2010
2	Dacarbazine (DIC)FDA LinkGeneric 01/2016 - 09/2015
2	PlatinumIBA 05/2012 - 05/2009
2	Fluorouracil (Carac)FDA LinkGeneric 11/2008 - 03/2007
2	Gefitinib (Iressa)FDA Link 11/2008 - 11/2005
1	Pharmaceutical PreparationsIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	entrectinibIBA 01/2021
1	AntibodiesIBA 01/2021
1	TropomyosinIBA 11/2019
1	A 17 (A-17)IBA 01/2019
1	Everolimus FDA Link 02/2018
1	LipidsIBA 02/2018
1	human ERBB2 proteinIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2017
1	Circulating Tumor DNAIBA 06/2017
1	Gemcitabine FDA Link 04/2016
1	130-nm albumin-bound paclitaxelIBA 04/2016
1	Calcibiotic Root Canal SealerIBA 10/2015
1	Codon (Codons)IBA 10/2015
1	Alkylating AgentsIBA 09/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2012
1	1-dodecylpyridoxal (PLD)IBA 05/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	thiaclopridIBA 05/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2011
1	thiamine triphosphorate (TTP)IBA 10/2009
1	Docetaxel (Taxotere)FDA Link 10/2009
1	Pemetrexed (MTA)FDA Link 05/2009
1	Leucovorin (Folinic Acid)FDA Link 11/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2004
1	Bleomycin (Blenoxane)FDA LinkGeneric 08/2003
1	Taxoids (Taxanes)IBA 08/2003
1	Vinorelbine (Navelbine)FDA LinkGeneric 08/2003
1	Biological ProductsIBA 08/2003
1	Methotrexate (Mexate)FDA LinkGeneric 08/2003
1	Filgrastim (Neupogen)FDA Link 01/2003
1	pegfilgrastim (Neulasta)FDA Link 01/2003
1	raltitrexed (D 1694)IBA 05/2002
1	ParaffinIBA 09/2001
1	Messenger RNA (mRNA)IBA 09/2001
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2001

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 08/2017 - 03/2000
14	Therapeutics 01/2022 - 03/2000
6	Stem Cell Transplantation 07/2011 - 03/2000
4	Transplantation 11/2004 - 03/2000
3	Hematopoietic Stem Cell Transplantation 11/2004 - 08/2003
2	Biological Therapy 04/2007 - 01/2007
2	Immunotherapy 01/2007 - 01/2004
1	Aftercare (After-Treatment) 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2012
1	Salvage Therapy 11/2010
1	Combination Drug Therapy (Combination Chemotherapy) 08/2003